-+ 0.00%
-+ 0.00%
-+ 0.00%

LŌKAHI THERAPEUTICS™ AND GLUCOTRACK CEO ERIK EMERSON PROVIDES STRATEGIC UPDATE ON LT-100, AI² PLATFORM GROWTH AND CLINICAL DEVELOPMENT PRIORITIES

Reuters·09/23/2026 13:00:03

Please log in to view news